Skip to content

Member

Isabel SERRA SÁNCHEZ

The Left · Spain

Group
The Left
Country
Spain
Roll-call participation
54.8 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
85.1 %ⓘ of 336 votes where the group had a line · The Left median 86.6 %
More facts (5)
National party
PODEMOS
In office
Since 16 Jul 2024
Against clear line
18 of 272 votesⓘ
Committees
DEVE, LIBE (substitute), PETI (substitute)
Member id
257009
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

54.8 %

340 of 620 final votes while in office

The Left median: 86.9 % (−32.1 pts)

Chamber median: 90.6 %

With majority line ⓘ

85.1 %

286 of 336 votes where their group had a line

The Left median: 86.6 % (−1.5 pts)

Against clear line ⓘ

6.6 %

18 of 272 votes where their group had a clear line

3 opposite (for ↔ against), 14 abstained against the line, 1 voted for or against when the line was to abstain

Abstention ⓘ

20.0 %

68 of 340 votes cast

Participation 54.8 % — The Left median 86.9 %, 47 members.ⓘ
Data as a table
Participation among the 47 members of the The Left with enough votes.
FigureParticipation
Isabel SERRA SÁNCHEZ54.8 %
The Left median86.9 %
Lowest in the group37.7 %
Highest in the group99.4 %
Members47
With majority line 85.1 % — The Left median 86.6 %, 47 members.ⓘ
Data as a table
With majority line among the 47 members of the The Left with enough votes.
FigureWith majority line
Isabel SERRA SÁNCHEZ85.1 %
The Left median86.6 %
Lowest in the group64.5 %
Highest in the group91.8 %
Members47
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of The Left; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: No vote recorded Majority line: Abstained
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: No vote recorded Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: No vote recorded Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: No vote recorded Majority line: Against
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: No vote recorded Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: No vote recorded Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: No vote recorded Majority line: Against

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 29 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within The Left

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Irene MONTERO The LeftSpain100 % of 3 310 shared87 %
Martin GÜNTHER The LeftGermany96 % of 1 600 shared87 %
Özlem DEMIREL The LeftGermany95 % of 3 037 shared87 %
Catarina MARTINS The LeftPortugal94 % of 3 458 shared87 %
Rudi KENNES The LeftBelgium94 % of 3 499 shared87 %
Estrella GALÁN The LeftSpain93 % of 2 984 shared87 %
Pernando BARRENA ARZA The LeftSpain93 % of 2 622 shared87 %
Martin SCHIRDEWAN The LeftGermany93 % of 3 104 shared87 %
Ilaria SALIS The LeftItaly92 % of 3 008 shared87 %
Konstantinos ARVANITIS The LeftGreece92 % of 2 636 shared87 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Ana MIRANDA PAZ GreensSpain85 % of 2 931 shared77 %
Vicent MARZÀ IBÁÑEZ GreensSpain84 % of 3 560 shared77 %
Benedetta SCUDERI GreensItaly83 % of 3 547 shared77 %
Cristina GUARDA GreensItaly82 % of 2 899 shared77 %
Jaume ASENS LLODRÀ GreensSpain82 % of 2 674 shared77 %
David CORMAND GreensFrance81 % of 3 428 shared77 %
Saskia BRICMONT GreensBelgium81 % of 3 376 shared77 %
Leoluca ORLANDO GreensItaly81 % of 2 970 shared77 %
Mélissa CAMARA GreensFrance81 % of 3 012 shared77 %
Marie TOUSSAINT GreensFrance80 % of 3 367 shared77 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on DevelopmentDEVE CommitteeMember19 Jul 2024now
Committee on Civil Liberties, Justice and Home AffairsLIBE CommitteeSubstitute19 Jul 2024now
Committee on PetitionsPETI CommitteeSubstitute19 Jul 2024now
Subcommittee on Human RightsDROI SubcommitteeVice-chair26 Jun 2025now
Delegation for relations with the countries of Central America, including the EU-Central America Association Parliamentary CommitteeDCAM DelegationMember19 Sept 2024now
Delegation to the Euro-Latin American Parliamentary AssemblyDLAT Parliamentary assemblyMember19 Sept 2024now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on Trade UnionsIG10-24 Intergroup / working groupMember31 Jan 2025now
Subcommittee on Human RightsDROI SubcommitteeMember19 Jul 202425 Jun 2025

Show all 9 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Establishing Global EuropeShadow rapporteurDEVE28 Jul 2026
shadow rapporteur for the AFET/DROI report \"Shaping the EU's external action to address the human rights challenges posed by artificial intelligence\" (2026/2005(INI)), Rapporteur: Nacho SÁNCHEZ AMOR (S&D). Trilogue negotiator4 Jun 2026
Shadow of DEVE Opinion on the Proposal for a Regulation of the European Parliament and of the Council amending Regulation (EU) 2024/1252 (Critical Raw Materials Act), DEVE Rapporteur for opinion: Marit MAIJ (S&D) Trilogue negotiator4 Jun 2026
Laying down rules to prevent and combat child sexual abuseShadow rapporteurLIBE10 Mar 2026
Establishing Global EuropeShadow rapporteurDEVE21 Jan 2026
Amending Regulation (EU) 2021/1232 as regards the extension of its period of applicationShadow rapporteurLIBE19 Jan 2026
Importance of consent-based rape legislation in the EUShadow rapporteurLIBE29 Apr 2025
Gender Equality Strategy 2025Shadow rapporteur for an opinionLIBE4 Mar 2025
2023 discharge: General budget of the EU - CommissionShadow rapporteur for an opinionDEVE14 Feb 2025
Financing for development – ahead of the Fourth International Conference on Financing for Development in SevilleShadow rapporteurDEVE13 Feb 2025

Show all 16 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

35 contributions recorded; 7 on behalf of their group; 47 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
15 Sept 2026The recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect the EU’s external borders (debate) Speech · 1 minRead
15 Sept 2026The recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect the EU’s external borders (debate) Speech · 1 minRead
8 Jul 2026The threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan Speech · 1 minRead
7 Jul 2026Presentation of the Action Plan on Cybersecurity and AI (debate) Speech · 1 minRead
17 Jun 2026Electrification Action Plan (debate) Speech · 1 minRead
19 May 2026Political repression and humanitarian situation in Cuba (debate) Speech · 1 minRead
29 Apr 2026Shortcomings and deficiencies of the ‘Amnesty Law’ in Venezuela Speech · 1 minRead
29 Apr 2026Sudan’s abandoned humanitarian crisis: three years of conflict (debate) Speech · 1 minRead
29 Apr 2026The need for targeted criminal provisions and platforms’ responsibility to effectively address cyberbullying and online harassment (debate) on behalf of The LeftSpeech · 2 minRead
27 Apr 2026Importance of consent-based rape legislation in the EU (debate) Speech · 2 minRead

Show all 35 recent contributions

Questions and motions, 108

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
24 Sept 2026Eviction of Maricarmen and police violence against protesters P-10-2026-003852Priority written questionwith 1 co-authorNot yet answered
16 Sept 2026Persecution and violence against LGBTI+ persons in Türkiye E-10-2026-003714Written questionwith 1 co-authorNot yet answered
14 Sept 2026MOTION FOR A RESOLUTION on the recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect the EU’s external borders B-10-2026-0412Motion for a resolutionwith 11 co-authors—
1 Sept 2026Serious statements by Markus Lammert regarding the expulsion of unaccompanied children and persons in need of international protection in Ceuta E-10-2026-003413Written questionwith 15 co-authorsNot yet answered
6 Aug 2026Discrimination against migrant children in care in Aragon and compatibility with EU law E-10-2026-003226Written questionNot yet answered
6 Aug 2026Protection of Daniel Arcuri Rivas after confirmation of his custody while the criminal trial for alleged ill-treatment continues E-10-2026-003217Written questionwith 1 co-authorNot yet answered
16 Jul 2026Humanitarian situation of Sahrawi refugees, inadequate EU humanitarian assistance and the growing water crisis in the refugee camps E-10-2026-003027Written questionwith 22 co-authors27 Aug 2026
15 Jul 2026Use of NextGenerationEU funds to finance the Benasque-Cerler cable car project ruled illegal by the Spanish courts E-10-2026-002996Written question2 Sept 2026
14 Jul 2026Human rights situation in Colombia E-10-2026-002907Written question13 Aug 2026
13 Jul 2026Drone attacks against civilians in Western Sahara E-10-2026-002880Written questionwith 9 co-authors14 Aug 2026

Show all 108 questions and motions

Amendments tabled in committee, 26

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
4 Sept 2026Shaping the EU's external action to address the human rights challenges posed by artificial intelligence AFET-AM-792029 AFET10
4 Sept 2026Shaping the EU's external action to address the human rights challenges posed by artificial intelligence AFET-AM-792048 AFET32
8 Jun 2026Strengthening global health resilience in partner countries DEVE-AM-789863 DEVE10
26 May 2026Establishing Global Europe CJ19-AM-789068 CJ1919
26 May 2026Establishing Global Europe CJ19-AM-789067 CJ1916
26 May 2026Establishing Global Europe CJ19-AM-789069 CJ1929
26 May 2026Establishing Global Europe CJ19-AM-789070 CJ1927
26 May 2026Establishing Global Europe CJ19-AM-789071 CJ1935
26 May 2026Establishing Global Europe CJ19-AM-789072 CJ1964
27 Apr 2026following the fact-finding mission to Extremadura and Castilla la Mancha (Spain) aiming to investigate the closure of a nuclear power plant in Almaraz based on Petition No 0445/2025 and the protection of the Cabañeros National Park based on Petitions Nos 0819/2024 and 1334/2024 PETI-AM-787840 PETI16

Show all 26 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Spain National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
1 October 2026

Cite as

EU Parl Watch Research (2026). “Isabel SERRA SÁNCHEZ”. Member record. memberId 257009. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/257009?page=77&scope=final&vscope=all (retrieved 1 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/257009. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/257009?format=application%2Fld%2Bjson (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-257009,
  author = {{EU Parl Watch Research}},
  title = {{Isabel SERRA SÁNCHEZ}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/257009?page=77&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/257009?page=77&scope=final&vscope=all},
  urldate = {2026-10-01},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 257009. Official source: https://www.europarl.europa.eu/meps/en/257009. Data: EP Open Data: member record (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}